Eli Lilly is cutting insulin prices and capping copays at $35: 5 questions answered
USC’s Dana Goldman and Karen Van Nuys explain why the drug company is dramatically cutting the cost of some of its insulin products and sum up how it may improve access to this essential medical treatment.